Kirby Daniel Gordon reported tax withholding involving 3,935 shares of IOVANCE BIOTHERAPEUTICS, INC. at $8.08 for −$31.8k on Nov 10, 2026

Tax withholding
Form 4 code F. Payment of an exercise price or tax liability by delivering or withholding securities in a Rule 16b-3 transaction.
Chief Commercial Officer
Chief Commercial Officer
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$31,794.80Shares × reported price
Shares traded
3,935Common Stock
Price per share
$8.08Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
160,576Direct
Trade date
Nov 10, 2026Tax withholding
Filed
Nov 12, 2026, 5:00 PM ET2-day reporting delay
Accession
0001104659-26-126319Code F · Transaction 399327
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 10, 2026Option exercise10,000$0.00$0Trade 399328
Nov 10, 2026Option exercise10,000$0.00$0Trade 399326
3 transaction rows in this filing. Joint filers share the same rows.

IOVA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
IOVA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +92%1w ago +11%1d ago +11%
Returns since7d30d90d180d1y

Footnotes in full

F1: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. F2: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3: Represents the common stock remaining after deducting the common stock withheld for taxes. F4: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5: The remaining RSUs will vest in equal quarterly installments. F6: Such aggregate number reflects the remainder of such RSUs granted on February 10, 2025, but does not include any other RSUs held by such Reporting Person.